{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:31:27Z","timestamp":1791210687836,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.ymgme.2006.10.005","type":"journal-article","created":{"date-parts":[[2006,12,13]],"date-time":"2006-12-13T17:14:00Z","timestamp":1166030040000},"page":"313-328","source":"Crossref","is-referenced-by-count":76,"title":["Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice"],"prefix":"10.1016","volume":"90","author":[{"given":"Kim M.","family":"Hemsley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Hopwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2006.10.005_bib1","first-page":"381","article-title":"The mucopolysaccharidoses. Diagnosis, molecular genetics and treatment","volume":"7","author":"Hopwood","year":"1990","journal-title":"Mol. Biol. Med."},{"key":"10.1016\/j.ymgme.2006.10.005_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng1295-465","article-title":"Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome","volume":"11","author":"Scott","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2006.10.005_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/dnares\/3.4.269","article-title":"Structure and sequence of the human sulphamidase gene","volume":"3","author":"Karageorgos","year":"1996","journal-title":"DNA Res."},{"key":"10.1016\/j.ymgme.2006.10.005_bib4","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2006.10.005_bib5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"Suppl","key":"10.1016\/j.ymgme.2006.10.005_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1651-2227.2002.tb03118.x","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report","volume":"91","author":"Muenzer","year":"2002","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2006.10.005_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1542\/peds.2004-1023","article-title":"Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase","volume":"115","author":"Harmatz","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2006.10.005_bib8","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2006.10.005_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A-replacement therapy in Fabry\u2019s disease","volume":"345","author":"Eng","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2006.10.005_bib10","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1073\/pnas.87.5.1913","article-title":"Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease","volume":"87","author":"Barton","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2006.10.005_bib11","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1073\/pnas.0506892102","article-title":"Overcoming the blood\u2013brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII","volume":"102","author":"Vogler","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2006.10.005_bib12","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1073\/pnas.0405042101","article-title":"Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood\u2013brain barrier","volume":"101","author":"Urayama","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2006.10.005_bib13","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/BF00711520","article-title":"Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype","volume":"16","author":"Hopwood","year":"1993","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2006.10.005_bib14","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894","article-title":"Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome","volume":"87","author":"Peters","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2006.10.005_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1701141","article-title":"Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation","volume":"21","author":"Yamada","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ymgme.2006.10.005_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00019052-199904000-00007","article-title":"Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux\u2013Lamy, and Sly syndromes, and Gaucher disease type III","volume":"12","author":"Krivit","year":"1999","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ymgme.2006.10.005_bib17","first-page":"359","article-title":"Stem cell bone marrow transplantation in patients with metabolic storage diseases","volume":"49","author":"Krivit","year":"2002","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.ymgme.2006.10.005_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.genom.4.070802.110415","article-title":"Enzyme therapy for lysosomal storage disease: principles, practice, and prospects","volume":"4","author":"Grabowski","year":"2003","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.ymgme.2006.10.005_bib19","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0140-6736(95)92597-X","article-title":"Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation","volume":"345","author":"Hoogerbrugge","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2006.10.005_bib20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1005526628598","article-title":"Bone marrow transplantation in mucopolysaccharidosis type IIIA: a comparison of an early treated patient with his untreated sibling","volume":"22","author":"Sivakumur","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2006.10.005_bib21","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/glycob\/9.12.1389","article-title":"A mouse model for mucopolysaccharidosis type IIIA (Sanfilippo syndrome)","volume":"9","author":"Bhaumik","year":"1999","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2006.10.005_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/glycob\/11.1.99","article-title":"A novel missense mutation in lysosomal sulfamidase is the basis of MPS III A in a spontaneous mouse mutant","volume":"11","author":"Bhattacharyya","year":"2001","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2006.10.005_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymgme.2004.07.016","article-title":"Purification and characterization of recombinant murine sulfamidase","volume":"83","author":"Gliddon","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2006.10.005_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1203\/01.PDR.0000129661.40499.12","article-title":"Enzyme replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice","volume":"56","author":"Gliddon","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2006.10.005_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ymgme.2004.05.005","article-title":"Intracerebral injection of sulfamidase delays neuropathology in murine MPS IIIA","volume":"82","author":"Savas","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2006.10.005_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbr.2004.08.019","article-title":"Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS IIIA)","volume":"158","author":"Hemsley","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ymgme.2006.10.005_bib27","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ana.10373","article-title":"Selective neurodegeneration in murine mucopolysaccharidosis VII is progressive and reversible","volume":"52","author":"Heuer","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2006.10.005_bib28","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2006.10.005_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymgme.2005.09.026","article-title":"Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA","volume":"87","author":"King","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2006.10.005_bib30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2004.07.003","article-title":"Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I","volume":"83","author":"Kakkis","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2006.10.005_bib31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0091-3057(98)00247-0","article-title":"New techniques in stereotaxic surgery and anesthesia in the mouse","volume":"63","author":"Messier","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ymgme.2006.10.005_bib32","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1203\/01.PDR.0000141987.69757.DD","article-title":"Disease specific markers for the mucopolysaccharidoses","volume":"56","author":"Fuller","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2006.10.005_bib33","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.ymgme.2006.10.005_bib34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11916-001-0068-0","article-title":"Spinal drug delivery","volume":"5","author":"Grabow","year":"2001","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.ymgme.2006.10.005_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/1566523013348445","article-title":"Vector delivery methods and targeting strategies for gene therapy of brain tumors","volume":"1","author":"Rainov","year":"2001","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ymgme.2006.10.005_bib36","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.4049\/jimmunol.157.11.5185","article-title":"Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis","volume":"157","author":"Koedel","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymgme.2006.10.005_bib37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1043-6618(02)00147-0","article-title":"Baclofen analgesia: involvement of the GABAergic system","volume":"46","author":"Balerio","year":"2002","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ymgme.2006.10.005_bib38","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.gt.3302735","article-title":"Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice","volume":"13","author":"Watson","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2006.10.005_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1750-3639.1998.tb00144.x","article-title":"Cellular pathology of lysosomal storage disorders","volume":"8","author":"Walkley","year":"1998","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymgme.2006.10.005_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0197-0186(01)00136-X","article-title":"Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid beta-peptides induced oxidative stress and reduces NF-kappaB activation","volume":"41","author":"Bisaglia","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ymgme.2006.10.005_bib41","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/jnr.10543","article-title":"Paracetamol effectively reduces prostaglandin E2 synthesis in brain macrophages by inhibiting enzymatic activity of cyclooxygenase but not phospholipase and prostaglandin E synthase","volume":"71","author":"Greco","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2006.10.005_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(98)00663-3","article-title":"Inflammatory molecule release by beta-amyloid-treated T98G astrocytoma cells: role of prostaglandins and modulation by paracetamol","volume":"360","author":"Landolfi","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymgme.2006.10.005_bib43","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jnr.20798","article-title":"Influence of caloric restriction on motor behaviour, longevity, and brain lipid composition in Sandhoff disease mice","volume":"83","author":"Denny","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ymgme.2006.10.005_bib44","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ana.20242","article-title":"NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynorjirimycin","volume":"56","author":"Jeyakumar","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2006.10.005_bib45","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(03)13311-9","article-title":"Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I","volume":"361","author":"Kakavanos","year":"2003","journal-title":"Lancet"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671920600326X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671920600326X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T23:20:34Z","timestamp":1707434434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671920600326X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S109671920600326X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2006.10.005","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}